TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 NOK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
1,408
|
1,032
|
1,265 |
| Financial expenses |
34
|
37
|
17 |
| Earnings before taxes |
96
|
-73
|
-113 |
| EBITDA |
197
|
14
|
-96 |
| Total assets |
448
|
491
|
467 |
| Current assets |
91
|
96
|
125 |
| Current liabilities |
230
|
377
|
275 |
| Equity capital |
217
|
114
|
192 |
| - share capital |
108
|
101
|
104 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
48.4%
|
23.2%
|
41.1% |
| Turnover per employee |
1,408
|
1,032
|
1,265 |
| Profit as a percentage of turnover |
6.8%
|
-7.1%
|
-8.9% |
| Return on assets (ROA) |
29.0%
|
-7.3%
|
-20.6% |
| Current ratio |
39.6%
|
25.5%
|
45.5% |
| Return on equity (ROE) |
44.2%
|
-64.0%
|
-58.9% |
| Change turnover |
302
|
-194
|
-790 |
| Change turnover % |
27%
|
-16%
|
-38% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.